526 Chem. Res. Toxicol., Vol. 9, No. 2, 1996
Tang and Abbott
(21) Tang, W., Borel, A. G., and Abbott, F. S. (1996) Conjugation of
glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-
2,4-pentadienoic acid, catalyzed by rat hepatic glutathione S-
transferases. Drug Metab. Dispos. (in press).
detected in the bile and urine of rats treated with (E)-2,4-diene
VPA (1 page). Ordering information is given on any current
masthead page.
(22) Straub, K. M., Rudewicz, P., and Garvie, C. (1987) ‘Metabolic
mapping’ of drugs: Rapid screening techniques for xenobiotic
metabolites with m.s./m.s. techniques. Xenobiotica 17, 413-422.
(23) DePierre, J . W., and Morgenstern, R. (1983) Comparison of the
distribution of microsomal and cytosolic glutathione S-transferase
activities in different organs of the rat. Biochem. Pharmacol. 32,
721-723.
(24) Kassahun, K., and Baillie, T. A. (1993) Cytochrome P-450-
mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a
pharmacologically-active metabolite of valproic acid, in rat liver
microsomal preparations. Drug Metab. Dispos. 21, 242-248.
(25) Borel, A. G., and Abbott, F. S. (1995) Characterization of novel
isocyanate-derived metabolites of the formamide N-formyl am-
phetamine with the combined use of electrospray mass spectrom-
etry and stable isotope methodology. Chem. Res. Toxicol. 8, 891-
899.
(26) Spahn-Langguth, H., and Benet, L. Z. (1992) Acyl glucuronides
revisited: Is the glucuronidation process a toxification as well as
a detoxification mechanism? Drug Metab. Rev. 24, 5-48.
(27) Dickinson, R. G., Hooper, W. D., and Eadie, M. J . (1984)
pH-Dependent rearrangement of the biosynthetic ester glucu-
ronide of valproic acid to â-glucuronidase-resistant forms. Drug
Metab. Dispos. 12, 247-252.
(28) Armstrong, R. N. (1991) Glutathione S-transferases: Reaction
mechanism, structure, and function. Chem. Res. Toxicol. 4, 131-
140.
(29) Mulder, G. J ., Coughtrie, M. W. H., and Burchell, B. (1990)
Glucuronidation. In Conjugation reactions in drug metabolism
(Mulder, G. J ., Ed.) pp 52-105, Taylor & Francis Ltd., London.
(30) Kassahun, K., Farrell, K., Zheng, J ., and Abbott, F. (1990)
Metabolic profiling of valproic acid in patients using negative-
ion chemical ionization gas chromatography-mass spectrometry.
J . Chromatogr. 527, 327-341.
(31) Loscher, W., Wahnschaffe, U., Honack, D., Wittfoht, W., and Nau,
H. (1992) Effects of valproate and E-2-en-valproate on functional
and morphological parameters of rat liver. I. Biochemical, histo-
pathological and pharmacokinetic studies. Epilepsy Res. 13, 187-
198.
(32) Fabre, G., Briot, C., Marti, E., Montseny, J .-P., Bourrie, M., Masse,
D., Berger, Y., and Cano, J .-P. (1992) 2-Valproate biotransfor-
mation using human liver microsomal fractions. Pharm. Weekbl.,
Sci. Ed. 14, 146-151.
(33) Lo¨scher, W., Nau, H., Wahnschaffe, U., Ho¨nack, D., Rundfeldt,
C., Wittfoht, W., and Bojic, U. (1993) Effects of valproate and E-2-
en valproate on functional and morphological parameters of rat
liver. II. Influence of phenobarbital comedication. Epilepsy Res.
15, 113-131.
(34) Faed, E. M. (1984) Properties of acyl glucuronides: implications
for studies of the pharmacokinetics and metabolism of acidic
drugs. Drug Metab. Rev. 15, 1213-1249.
(35) Shore, L. J ., Fenselau, C., King, A. R., and Dickinson, R. G. (1995)
Characterization and formation of the glutathione conjugate of
clofibric acid. Drug Metab. Dispos. 23, 119-123.
(36) Zia-Amirhosseini, P., Spahn-Langguth, H., and Benet, L. Z. (1994)
Bioactivation by glucuronide-conjugate formation. Adv. Pharma-
col. 27, 385-397.
(37) Ding, A., Ojingwa, J . C., McDonagh, A. F., Burlingame, A. L.,
and Benet, L. Z. (1993) Evidence for covalent binding of acyl
glucuronides to serum albumin via an imine mechanism as
revealed by tandem mass spectrometry. Proc. Natl. Acad. Sci.
U.S.A. 90, 3797-3801.
(38) J ezequel, A. M., Bonazzi, P., Novelli, G., Venturini, C., and
Orlandi, F. (1984) Early structural and functional changes in liver
of rats treated with a single dose of valproic acid. Hepatology 4,
1159-1166.
(39) Cotariu, D., Evans, S., Zaidman, J . L., and Marcus, O. (1990)
Early changes in hepatic redox homeostasis following treatment
with a single dose of valproic acid. Biochem. Pharmacol. 40, 589-
593.
(40) DeLeve, L. D., and Kaplowitz, N. (1991) Glutathione metabolism
and its role in hepatotoxicity. Pharmacol. Ther. 52, 287-305.
(41) Hawkins, E., and Brewer, E. (1993) Case 4: Renal toxicity induced
by valproic acid (Depakene). Pediatr. Pathol. 13, 863-868.
Refer en ces
(1) Baillie, T. A., and Rettenmeier, A. W. (1989) Valproate: Biotrans-
formation. In Antiepileptic Drugs (Levy, R. H., Mattson, R. H.,
Meldrum, B. S., and Penry, J . K., Eds.), pp. 601-619, Raven
Press, New York.
(2) Dickinson, R. G., Harland, R. C., Ilias, A. M., Rodgers, R. M.,
Kaufman, S. N., Lynn, R. K., and Gerber, N. (1979) Disposition
of valproic acid in the rat: Dose-dependent metabolism, distribu-
tion, enterohepatic recirculation and choleretic effect. J . Phar-
macol. Exp. Ther. 211, 583-595.
(3) Dickinson, R. G., Hooper, W. D., Dunstan, P. R., and Eadie, M.
J . (1989) Urinary excretion of valproate and some metabolites in
chronically treated patients. Ther. Drug Monit. 11, 127-133.
(4) Baillie, T. A. (1988) Metabolic activation of valproic acid and drug-
mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-
4-pentenoic acid. Chem. Res. Toxicol. 1, 195-199.
(5) Zimmerman, H. J ., and Ishak, K. G. (1982) Valproate-induced
hepatic injury: Analysis of 23 fatal cases. Hepatology 2, 591-
597.
(6) Kesterson, J . W., Granneman, G. R., and Machinist, J . (1984) The
hepatotoxicity of valproic acid and its metabolites in rats. I.
Toxicologic, biochemical and histopathologic studies. Hepatology
4, 1143-1152.
(7) Kingsley, E., Gray, P., Tolman, K. G., and Tweedale, R. (1983)
The toxicity of metabolites of sodium valproate in cultured
hepatocytes. J . Clin. Pharmacol. 23, 178-185.
(8) Bjorge, S. M., and Baillie, T. A. (1985) Inhibition of medium-chain
fatty acid â-oxidation in vitro by valproic acid and its unsaturated
metabolite, 2-n-propyl-4-pentenoic acid. Biochem. Biophys. Res.
Commun. 132, 242-252.
(9) Ponchaut, S., van Hoof, F., and Veitch, K. (1992) In vitro effects
of valproate and valproate metabolites on mitochondrial oxida-
tions. Relevance of Co A sequestration to the observed inhibitions.
Biochem. Pharmacol. 43, 2435-2442.
(10) Porubek, D. J ., Grillo, M. P., and Baillie, T. A. (1989) The covalent
binding to protein of valproic acid and its hepatotoxic metabolite,
2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepato-
cytes. Drug Metab. Dispos. 17, 123-130.
(11) Prickett, K. S., and Baillie, T. A. (1986) Metabolism of unsaturated
derivatives of valproic acid in rat liver microsomes and destruction
of cytochrome P-450. Drug Metab. Dispos. 14, 221-229.
(12) Kassahun, K., Farrell, K., and Abbott, F. (1991) Identification and
characterization of the glutathione and N-acetylcysteine conju-
gates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of
valproic acid, in rats and humans. Drug Metab. Dispos. 19, 525-
535.
(13) Tang, W., Borel, A. G., Fujimiya, T., and Abbott, F. S. (1995)
Fluorinated analogues as mechanistic probes in valproic acid
hepatotoxicity: Hepatic microvesicular steatosis and glutathione
status. Chem. Res. Toxicol. 8, 671-682.
(14) Kassahun, K., Hu, P., Grillo, M. P., Davis, M. R., J in, L., and
Baillie, T. A. (1994) Metabolic activation of unsaturated deriva-
tives of valproic acid. Identification of novel glutathione adducts
formed through coenzyme A-dependent and -independent pro-
cesses. Chem.-Biol. Interact. 90, 253-275.
(15) Zheng, J . J . (1993) Metabolism and pharmacokinetic studies of
valproic acid using stable isotope techniques. M.Sc. Thesis, The
University of British Columbia (Vancouver). 147 pp.
(16) Curci, R., Fiorentino, M., Troisi, L., Edwards, J . O., and Pater,
R. H. (1980) Epoxidation of alkenes by dioxirane intermediates
generated in the reaction of potassium caroate with ketones. J .
Org. Chem. 45, 4758-4760.
(17) Williams, A. M., Worrall, S., J ersey, J . D., and Dickinson, R. G.
(1992) Studies on the reactivity of acyl glucuronides. III. Glucu-
ronide-derived adducts of valproic acid and plasma protein and
anti-adduct antibodies in humans. Biochem. Pharmacol. 43, 745-
755.
(18) Siekevitz, P. (1962) Preparation of microsomes and submicrosomal
fraction: Mammalian. Methods Enzymol. 5, 61-68.
(19) Habig, W. H., Pabst, M. J ., and J akoby, W. B. (1974) Glutathion
S-transferases: The first enzymatic step in mercapturic acid
formation. J . Biol. Chem. 249, 7130-7139.
(20) Erve, J . C., Deinzer, M. L., and Reed, D. J . (1995) Alkylation of
oxytocin by S-(2-chloroethyl)glutathione and characterization of
adducts by tandem mass spectrometry and Edman degradation.
Chem. Res. Toxicol. 8, 414-421.
TX950120Y